GET A VALUABLE CERTIFICATE FOR JOB MARKET


ACADEMIC RECOGNITION OF 3 OR 6 CREDITS


DESIGNED FOR EXPERTS BY EXPERTS


THE PUBLIC HEALTH IMPACT OF ADVERSE DRUG REACTIONS


OBJECTIVES



To critically use data from experimental and observational studies to evaluate the public health impact of selected adverse drug reactions.

To design and to carry out an analysis of the impact of adverse effects at a community level.

To analyse the economic impact of adverse drug reactions on public health.

Economical impact, risk, population, community, real use of medicines, benefit/risk, therapeutic uncertainty

 

MODULE PARTS



  1. Data generalization: from particular cases to population impact-1. The interpretation of the results of clinical trials and meta-analyses from the public health point of view
  2. Data generalization: from particular cases to population impact-2. Examples of the value of observational studies and meta-analyses of observational studies in the evaluation of the public health impact of medicines use.
  3. Public health impact - Case: Hormone replacement therapy
  4. Public health impact: Beyond case - Control studies
  5. The importance of the denominator: case-population studies. The future of pharmacovigilance.

 

TRAINER TEAM



Coordinator: Prof Albert Figueras (from Universitat Autònoma de Barcelona)

Expert(s): Janice Fuller (from Amgen NV), Prof Joan-Ramon Laporte, Josep Maria Castel, Eduard Diogène (from Universitat Autònoma de Barcelona), Jamie Robinson (from F. Hoffmann-La Roche Ltd), Ulf Bergman (from Karolinska Institutet).

Advanced level
75 h workload over 3 months (3 ECTS credits)
Key dates
Course calendar
Certificate award
or included in Master Year 2 or PhD programme
English language
Online based learning
Student: 1,500 €
Professional: 3,000 €
  Savings could be offered under eligibility conditions.

APPLY NOW

Applications open until March 23rd, 2018

Or include this module in your training curriculum choices...

Master Year 2 PhD



Confused? Read the FAQs...

NEED TO TALK TO US?

+33 5 47 30 42 69

Monday-Friday / 9.00am-6.00pm CET

 

Supported By

IMI logo EU logo efpia logo

Created By

Eu2P Partners